An enveloped virus-like particle vaccine expressing a stabilized prefusion form of the SARS-CoV-2 spike protein elicits potent immunity after a single dose.
A.-C. Fluckiger, B. Ontsouka, J. Bozic, A. Diress, T. Ahmed, T. Berthoud, M. Liao, A. Tran, D. Duque, M. McCluskie, F. Diaz-Mitoma, D. E. Anderson, C. Soare
This paper evaluates an enveloped virus-like particle vaccine, VBI-2902a, which elicits strong immunity against SARS-CoV-2 after a single dose in mice and hamsters.
bioRxiv · Apr 28, 2021Immunology